K-pop

Jang Yoon-jung’s Mother Allegedly Used Her Estranged Daughter’s Name in an Investment Scam

Victims' Side: "We Haven't Received a Refund of Our 30 Million Won Investment" Jang Yoon-jung's Representative: "Jang Yoon-jung Has Not Been in Contact with Her Mother"

[Edaily Starin KIM HYUNSIK Reporter] Allegations have surfaced that Ms. A, the mother of singer Jang Yoon-jung, committed fraud by using her daughter’s name despite having cut ties with her.
Jang Yoon-jung (Photo = Edaily DB)
In its broadcast on the 30th, JTBC’s “Case Squad” covered the story of Ms. B, a woman in her 60s who claims she was the victim of an investment scam perpetrated by Ms. A, Jang Yoon-jung’s mother.
Ms. B claimed that Ms. A deceived her by claiming to be in contact with Jang Yoon-jung and promising she could earn a large sum of money by investing in TV Chosun’s “Mr. Trot.” She alleged that she handed over 30 million won but has not received a refund.
“Case Squad” reported that Ms. B’s daughter filed a criminal complaint against Ms. A on charges of fraud last April, and that there is another victim who claims to have been defrauded using a similar scheme.
Jang Yoon-jung’s representatives issued a statement through “Case Squad,” saying, “Jang Yoon-jung has never communicated directly with her mother,” and added, “Although her mother attempted to contact her several times through acquaintances, Jang Yoon-jung did not respond.”
Meanwhile, Jang Yoon-jung revealed in 2013 that her mother, Ms. A, and her younger brother had squandered all the money she had earned from her singing career and left her with 1 billion won in debt. Following a legal battle, she subsequently announced that she had severed ties with her mother.

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02